Narcolepsy Drugs Market Regional Analysis

North America is estimated to emerge as the leader in terms of narcolepsy drug demand owing to high awareness regarding mental health and growing prevalence of narcolepsy. Growing investments in the research and development of novel narcolepsy drugs and surging incidence of sleep disorders are also aiding the dominance of North America. The United States and Canada are estimated to be the top markets for narcolepsy drug providers operating in this region. High availability of favorable reimbursement policies for narcolepsy treatment in North America is also anticipated to bolster the sales of narcolepsy drugs going forward.  

The Asia Pacific region is emerging as a highly opportune market for narcolepsy drug companies in the world. Launch of new initiatives to promote awareness regarding narcolepsy, high investments in healthcare infrastructure development, and high emphasis on improving quality of life are expected to promote sales of narcolepsy drugs in this region. China and India are expected to be the leading markets for narcolepsy drugs in the Asia Pacific region across the study period and beyond. High investments in sleep medicine R&D are also expected to create new opportunities for narcolepsy drug companies.